Redpoint Investment Management Pty LTD Sarepta Therapeutics, Inc. Transaction History

Redpoint Investment Management Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 13, 2021	SELL	$72.25 - $168.95 $94,936 - $222,000	-1,314 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$125.56 - $178.74 $164,985 - $234,864	1,314 New	1,314 $224,000
Q3 2020 Oct 09, 2020	SELL	$127.12 - $172.34 $167,035 - $226,454	-1,314 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$93.0 - $171.7 $122,202 - $225,613	1,314 New	1,314 $211,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.